$SGRY
Surgery Partners, Inc.

2022 Q3 Form 10-Q Financial Statement

#000163883322000122 Filed on August 02, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2021 Q4
Revenue $620.6M $615.4M $610.2M
YoY Change 10.98% 13.27% 11.29%
Cost Of Revenue $467.8M $460.6M $441.3M
YoY Change 13.19% 14.46% 13.1%
Gross Profit $152.8M $154.8M $168.9M
YoY Change 4.73% 9.87% 6.83%
Gross Profit Margin 24.62% 25.15% 27.68%
Selling, General & Admin $39.50M $46.30M $49.00M
YoY Change -19.22% -1.7% 5.38%
% of Gross Profit 25.85% 29.91% 29.01%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $29.80M $28.00M $22.70M
YoY Change 18.25% 11.11% -10.98%
% of Gross Profit 19.5% 18.09% 13.44%
Operating Expenses $546.5M $538.9M $59.50M
YoY Change 10.27% 11.39% -17.36%
Operating Profit $74.10M $76.50M $109.4M
YoY Change 16.51% 28.57% 27.06%
Interest Expense -$60.70M -$56.90M -$57.30M
YoY Change 11.99% 6.55% 12.8%
% of Operating Profit -81.92% -74.38% -52.38%
Other Income/Expense, Net $1.100M $0.00
YoY Change
Pretax Income $13.40M $19.60M $54.70M
YoY Change 42.55% 221.31% 29.31%
Income Tax $7.800M $4.300M $11.80M
% Of Pretax Income 58.21% 21.94% 21.57%
Net Earnings -$25.00M -$18.40M -$100.0K
YoY Change 9.17% -31.6% -101.82%
Net Earnings / Revenue -4.03% -2.99% -0.02%
Basic Earnings Per Share -$0.28 -$0.21
Diluted Earnings Per Share -$0.28 -$0.21 -$1.181K
COMMON SHARES
Basic Shares Outstanding 89.94M shares 88.90M shares 82.44M shares
Diluted Shares Outstanding 88.91M shares 88.90M shares

Balance Sheet

Concept 2022 Q3 2022 Q2 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $154.8M $227.4M $389.9M
YoY Change -53.15% -51.08% 22.65%
Cash & Equivalents $154.8M $227.4M $389.9M
Short-Term Investments
Other Short-Term Assets $56.60M $47.60M $39.30M
YoY Change 96.53% 72.46% 43.43%
Inventory $68.60M $64.00M $61.10M
Prepaid Expenses $36.00M $37.40M $25.60M
Receivables $422.3M $412.0M $430.2M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $738.3M $788.4M $946.1M
YoY Change -12.28% -17.26% 18.04%
LONG-TERM ASSETS
Property, Plant & Equipment $1.151B $1.067B $953.8M
YoY Change 33.39% 23.67% 11.59%
Goodwill $4.145B $3.993B $3.912B
YoY Change 14.71% 14.48% 12.8%
Intangibles $43.70M
YoY Change -6.82%
Long-Term Investments $189.1M $159.7M $88.70M
YoY Change 111.05% 76.46% -2.1%
Other Assets $169.1M $130.6M $59.10M
YoY Change 236.18% 155.58% 118.89%
Total Long-Term Assets $5.798B $5.503B $5.172B
YoY Change 21.05% 17.9% 12.14%
TOTAL ASSETS
Total Short-Term Assets $738.3M $788.4M $946.1M
Total Long-Term Assets $5.798B $5.503B $5.172B
Total Assets $6.537B $6.292B $6.118B
YoY Change 16.07% 11.94% 13.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $138.4M $126.4M $124.9M
YoY Change 18.8% 15.86% 24.65%
Accrued Expenses $225.5M $230.8M $215.0M
YoY Change 10.7% 15.0% -3.76%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $116.9M $68.30M $60.40M
YoY Change 92.27% -1.87% -6.21%
Total Short-Term Liabilities $624.3M $521.7M $536.8M
YoY Change 15.5% -1.92% -3.59%
LONG-TERM LIABILITIES
Long-Term Debt $3.103B $3.019B $2.878B
YoY Change 11.13% 8.37% 3.08%
Other Long-Term Liabilities $95.60M $96.40M $87.00M
YoY Change -23.15% -36.45% -37.72%
Total Long-Term Liabilities $95.60M $96.40M $87.00M
YoY Change -23.15% -36.45% -37.72%
TOTAL LIABILITIES
Total Short-Term Liabilities $624.3M $521.7M $536.8M
Total Long-Term Liabilities $95.60M $96.40M $87.00M
Total Liabilities $719.9M $618.1M $623.8M
YoY Change 8.27% -9.58% -10.44%
SHAREHOLDERS EQUITY
Retained Earnings -$533.9M -$508.9M -$502.7M
YoY Change 6.23% 6.09% 16.42%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.173B $1.155B $1.089B
YoY Change
Total Liabilities & Shareholders Equity $6.537B $6.292B $6.118B
YoY Change 16.07% 11.94% 13.01%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2021 Q4
OPERATING ACTIVITIES
Net Income -$25.00M -$18.40M -$100.0K
YoY Change 9.17% -31.6% -101.82%
Depreciation, Depletion And Amortization $29.80M $28.00M $22.70M
YoY Change 18.25% 11.11% -10.98%
Cash From Operating Activities $29.70M $42.10M $19.70M
YoY Change 99.33% 1730.43% 121.35%
INVESTING ACTIVITIES
Capital Expenditures -$17.30M -$22.40M -$14.10M
YoY Change 11.61% 65.93% -6.62%
Acquisitions
YoY Change
Other Investing Activities -$37.00M -$111.9M -$175.9M
YoY Change -56.73% 767.44% 119.6%
Cash From Investing Activities -$54.30M -$134.3M -$190.0M
YoY Change -46.24% 408.71% 99.58%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -48.00M -59.30M 229.8M
YoY Change -0.62% 11.89% -601.75%
NET CHANGE
Cash From Operating Activities 29.70M 42.10M 19.70M
Cash From Investing Activities -54.30M -134.3M -190.0M
Cash From Financing Activities -48.00M -59.30M 229.8M
Net Change In Cash -72.60M -151.5M 59.50M
YoY Change -45.98% 96.5% -145.04%
FREE CASH FLOW
Cash From Operating Activities $29.70M $42.10M $19.70M
Capital Expenditures -$17.30M -$22.40M -$14.10M
Free Cash Flow $47.00M $64.50M $33.80M
YoY Change 54.61% 308.23% 40.83%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001638833
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
CY2022Q2 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2021Q4 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2021Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent
CY2022Q2 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent
CY2022Q2 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligationsCurrent
CY2021Q4 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligationsCurrent
CY2021Q4 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligations
CY2022Q2 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligations
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
89935287 shares
dei Entity File Number
EntityFileNumber
001-37576
dei Entity Registrant Name
EntityRegistrantName
Surgery Partners, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-3620923
dei Entity Address Address Line1
EntityAddressAddressLine1
310 Seven Springs Way, Suite 500
dei Entity Address City Or Town
EntityAddressCityOrTown
Brentwood
dei Entity Address State Or Province
EntityAddressStateOrProvince
TN
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
37027
dei City Area Code
CityAreaCode
615
dei Local Phone Number
LocalPhoneNumber
234-5900
dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
dei Trading Symbol
TradingSymbol
SGRY
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
227400000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
389900000 usd
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
412000000.0 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
430200000 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
64000000.0 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
61100000 usd
CY2022Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
37400000 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
25600000 usd
CY2022Q2 us-gaap Other Assets Current
OtherAssetsCurrent
47600000 usd
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
39300000 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
788400000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
946100000 usd
CY2022Q2 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
320700000 usd
CY2021Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
272300000 usd
CY2022Q2 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
789100000 usd
CY2021Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
629700000 usd
CY2022Q2 sgry Medicare Accelerated Payments And Deferred Governmental Grants Current
MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent
21400000 usd
CY2021Q4 sgry Medicare Accelerated Payments And Deferred Governmental Grants Current
MedicareAcceleratedPaymentsAndDeferredGovernmentalGrantsCurrent
64400000 usd
CY2022Q2 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
4035600000 usd
CY2021Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
3955500000 usd
CY2022Q2 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
159700000 usd
CY2021Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
88700000 usd
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
277800000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
324100000 usd
CY2022Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
110400000 usd
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
114400000 usd
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
130600000 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
59100000 usd
CY2022Q2 us-gaap Assets
Assets
6291600000 usd
CY2021Q4 us-gaap Assets
Assets
6117600000 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
126400000 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
124900000 usd
CY2022Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
83800000 usd
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
77100000 usd
CY2022Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
221800000 usd
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
210000000.0 usd
CY2022Q2 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
68300000 usd
CY2021Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
60400000 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
521700000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
536800000 usd
CY2022Q2 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
3019400000 usd
CY2021Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
2878400000 usd
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
271800000 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
315600000 usd
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
96400000 usd
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
87000000.0 usd
CY2022Q2 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
341800000 usd
CY2021Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
330200000 usd
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20310000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20310000 shares
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
89935287 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
89935287 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
89332557 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
89332557 shares
CY2022Q2 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
900000 usd
CY2021Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
900000 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1618800000 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1622300000 usd
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
44300000 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-31500000 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-508900000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-502700000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
1155100000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1089000000 usd
CY2022Q2 us-gaap Minority Interest
MinorityInterest
885400000 usd
CY2021Q4 us-gaap Minority Interest
MinorityInterest
880600000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2040500000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1969600000 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6291600000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6117600000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
615400000 usd
CY2021Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
543300000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1211600000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1055700000 usd
CY2022Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
181900000 usd
CY2021Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
155300000 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
360800000 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
307000000.0 usd
CY2022Q2 us-gaap Supplies Expense
SuppliesExpense
173500000 usd
CY2021Q2 us-gaap Supplies Expense
SuppliesExpense
157500000 usd
us-gaap Supplies Expense
SuppliesExpense
345100000 usd
us-gaap Supplies Expense
SuppliesExpense
304800000 usd
CY2022Q2 us-gaap Professional Fees
ProfessionalFees
66700000 usd
CY2021Q2 us-gaap Professional Fees
ProfessionalFees
57400000 usd
us-gaap Professional Fees
ProfessionalFees
130300000 usd
us-gaap Professional Fees
ProfessionalFees
112900000 usd
CY2022Q2 sgry Operating And Finance Lease Expense
OperatingAndFinanceLeaseExpense
20200000 usd
CY2021Q2 sgry Operating And Finance Lease Expense
OperatingAndFinanceLeaseExpense
22600000 usd
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
24500000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
55600000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
51300000 usd
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
28000000.0 usd
sgry Operating And Finance Lease Expense
OperatingAndFinanceLeaseExpense
40200000 usd
sgry Operating And Finance Lease Expense
OperatingAndFinanceLeaseExpense
45400000 usd
CY2022Q2 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
38500000 usd
CY2021Q2 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
32200000 usd
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
75800000 usd
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
63800000 usd
CY2022Q2 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
480800000 usd
CY2021Q2 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
425000000.0 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
952200000 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
833900000 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
26100000 usd
CY2021Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
25200000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
55400000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
50900000 usd
CY2022Q2 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
8200000 usd
CY2021Q2 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
9200000 usd
us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
15300000 usd
us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
14500000 usd
CY2022Q2 sgry Grant Revenue
GrantRevenue
100000 usd
CY2021Q2 sgry Grant Revenue
GrantRevenue
4900000 usd
sgry Grant Revenue
GrantRevenue
1300000 usd
sgry Grant Revenue
GrantRevenue
20000000.0 usd
CY2022Q2 sgry Gain Loss On Disposition Of Assets And Deconsolidation
GainLossOnDispositionOfAssetsAndDeconsolidation
-1100000 usd
CY2021Q2 sgry Gain Loss On Disposition Of Assets And Deconsolidation
GainLossOnDispositionOfAssetsAndDeconsolidation
-1000000.0 usd
sgry Gain Loss On Disposition Of Assets And Deconsolidation
GainLossOnDispositionOfAssetsAndDeconsolidation
-1000000.0 usd
sgry Gain Loss On Disposition Of Assets And Deconsolidation
GainLossOnDispositionOfAssetsAndDeconsolidation
-100000 usd
CY2022Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2600000 usd
CY2021Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
3000000.0 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
5700000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
5600000 usd
CY2022Q2 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
0 usd
CY2021Q2 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
0 usd
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
32800000 usd
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
0 usd
CY2022Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2021Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-9600000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-9600000 usd
CY2022Q2 us-gaap Other Nonrecurring Income Expense
OtherNonrecurringIncomeExpense
-2600000 usd
CY2021Q2 us-gaap Other Nonrecurring Income Expense
OtherNonrecurringIncomeExpense
-2800000 usd
us-gaap Other Nonrecurring Income Expense
OtherNonrecurringIncomeExpense
-5000000.0 usd
us-gaap Other Nonrecurring Income Expense
OtherNonrecurringIncomeExpense
-2800000 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
538900000 usd
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
483800000 usd
us-gaap Operating Expenses
OperatingExpenses
1034700000 usd
us-gaap Operating Expenses
OperatingExpenses
931900000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
76500000 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
59500000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
176900000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
123800000 usd
CY2022Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-56900000 usd
CY2021Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-53400000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-113200000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-106700000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
19600000 usd
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
6100000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
63700000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
17100000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4300000 usd
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2700000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5600000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2500000 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
15300000 usd
CY2021Q2 us-gaap Profit Loss
ProfitLoss
8800000 usd
us-gaap Profit Loss
ProfitLoss
58100000 usd
us-gaap Profit Loss
ProfitLoss
19600000 usd
CY2022Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
33700000 usd
CY2021Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
35700000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
64300000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
67500000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-18400000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-26900000 usd
us-gaap Net Income Loss
NetIncomeLoss
-6200000 usd
us-gaap Net Income Loss
NetIncomeLoss
-47900000 usd
CY2022Q2 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0 usd
CY2021Q2 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0 usd
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0 usd
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
10300000 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-18400000 usd
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-26900000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6200000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-58200000 usd
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.21
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.39
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.94
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.21
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.39
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.94
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
88900000 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
69267000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
88450000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
62060000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
88900000 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
69267000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
88450000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62060000 shares
CY2022Q2 us-gaap Profit Loss
ProfitLoss
15300000 usd
CY2021Q2 us-gaap Profit Loss
ProfitLoss
8800000 usd
us-gaap Profit Loss
ProfitLoss
58100000 usd
us-gaap Profit Loss
ProfitLoss
19600000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
19000000.0 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
200000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
75800000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
6600000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
34300000 usd
CY2021Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
9000000.0 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
133900000 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
26200000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
33700000 usd
CY2021Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
35700000 usd
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
64300000 usd
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
67500000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
600000 usd
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-26700000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
69600000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-41300000 usd
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
882100000 usd
CY2021Q1 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
100000 usd
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-2800000 usd
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
10300000 usd
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
248300000 usd
CY2021Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
6400000 usd
CY2021Q1 sgry Non Controlling Interest Acquisitions And Disposals Of Interests Held By Non Controlling Interest Holders Net
NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet
2300000 usd
CY2021Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
20800000 usd
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1105300000 usd
CY2021Q2 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
-4900000 usd
CY2021Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
3700000 usd
CY2021Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
439700000 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
200000 usd
CY2021Q2 sgry Non Controlling Interest Acquisitions And Disposals Of Interests Held By Non Controlling Interest Holders Net
NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet
5600000 usd
CY2021Q2 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
22300000 usd
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1527300000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1969600000 usd
CY2022Q1 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
32200000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
7700000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
56800000 usd
CY2022Q1 sgry Non Controlling Interest Acquisitions And Disposals Of Interests Held By Non Controlling Interest Holders Net
NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet
-29100000 usd
CY2022Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
24600000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2012600000 usd
CY2022Q2 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
4300000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4400000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
19000000.0 usd
CY2022Q2 sgry Non Controlling Interest Acquisitions And Disposals Of Interests Held By Non Controlling Interest Holders Net
NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet
27900000 usd
CY2022Q2 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
27700000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2040500000 usd
us-gaap Profit Loss
ProfitLoss
58100000 usd
us-gaap Profit Loss
ProfitLoss
19600000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
55400000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
50900000 usd
sgry Noncash Interest Income Expense Net
NoncashInterestIncomeExpenseNet
-12400000 usd
sgry Noncash Interest Income Expense Net
NoncashInterestIncomeExpenseNet
-5700000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
8000000.0 usd
us-gaap Share Based Compensation
ShareBasedCompensation
9300000 usd
sgry Gain Loss On Disposition Of Assets And Deconsolidation
GainLossOnDispositionOfAssetsAndDeconsolidation
-1000000.0 usd
sgry Gain Loss On Disposition Of Assets And Deconsolidation
GainLossOnDispositionOfAssetsAndDeconsolidation
-100000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-9600000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
4900000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-3200000 usd
us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
400000 usd
us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
400000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
17100000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
20000000.0 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-5400000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3100000 usd
sgry Increase Decrease In Medicare Accelerated Payments And Deferred Governmental Grants
IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants
-40200000 usd
sgry Increase Decrease In Medicare Accelerated Payments And Deferred Governmental Grants
IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants
-28800000 usd
sgry Increase Decrease In Settlement Payments
IncreaseDecreaseInSettlementPayments
0 usd
sgry Increase Decrease In Settlement Payments
IncreaseDecreaseInSettlementPayments
32200000 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-200000 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-5000000.0 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
121900000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
52500000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
40600000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
28000000.0 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
74900000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
15200000 usd
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
0 usd
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
2500000 usd
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
65800000 usd
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
0 usd
us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
11500000 usd
us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
0 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
11600000 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-181400000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-40700000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
33300000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
309400000 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
12400000 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
283100000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
8700000 usd
sgry Debt Instrument Prepayment Penalty Amount
DebtInstrumentPrepaymentPenaltyAmount
0 usd
sgry Debt Instrument Prepayment Penalty Amount
DebtInstrumentPrepaymentPenaltyAmount
2400000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
260900000 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
12700000 usd
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
0 usd
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
5100000 usd
us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
75200000 usd
us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
63400000 usd
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
4000000.0 usd
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
3400000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-2900000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-10900000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-103000000.0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
134800000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-162500000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
146600000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
389900000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
318200000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
227400000 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
464800000 usd
CY2022Q2 sgry Number Of Surgical Facilities Owned
NumberOfSurgicalFacilitiesOwned
133 facility
CY2022Q2 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
32 state
CY2022Q2 sgry Number Of Surgical Facilities Owned Majority Interest
NumberOfSurgicalFacilitiesOwnedMajorityInterest
85 facility
CY2022Q2 sgry Number Of Surgical Facilities Owned Consolidated
NumberOfSurgicalFacilitiesOwnedConsolidated
109 facility
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and footnotes. Examples include, but are not limited to, estimates of accounts receivable allowances, professional and general liabilities and the estimate of deferred tax assets or liabilities. Actual results could differ from those estimates.</span></div>
CY2022Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
615400000 usd
CY2021Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
543300000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1211600000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1055700000 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.088
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.146
us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
-4600000 usd
us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-1800000 usd
us-gaap Income Tax Reconciliation Disposition Of Business
IncomeTaxReconciliationDispositionOfBusiness
-1000000 usd
us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
-4100000 usd
us-gaap Income Tax Reconciliation Disposition Of Business
IncomeTaxReconciliationDispositionOfBusiness
-3000000 usd
CY2021Q4 us-gaap Goodwill
Goodwill
3911800000 usd
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
110700000 usd
sgry Goodwill Written Off Related To Sale Of Business Unit And Deconsolidation
GoodwillWrittenOffRelatedToSaleOfBusinessUnitAndDeconsolidation
29400000 usd
CY2022Q2 us-gaap Goodwill
Goodwill
3993100000 usd
CY2021Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
330200000 usd
CY2020Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
306800000 usd
us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
21600000 usd
us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
24400000 usd
sgry Redeemable Noncontrolling Interest Increase Decrease From Redemptions Or Purchase Of Interests
RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests
12900000 usd
sgry Redeemable Noncontrolling Interest Increase Decrease From Redemptions Or Purchase Of Interests
RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests
1900000 usd
sgry Redeemable Noncontrolling Interest Decrease From Distributions To Noncontrolling Interest Holders
RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
22900000 usd
sgry Redeemable Noncontrolling Interest Decrease From Distributions To Noncontrolling Interest Holders
RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
20300000 usd
CY2022Q2 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
341800000 usd
CY2021Q2 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
312800000 usd
sgry Proceeds From Government Assistance
ProceedsFromGovernmentAssistance
1000000 usd
CY2022Q2 sgry Proceeds From Government Assistance
ProceedsFromGovernmentAssistance
1000000 usd
sgry Proceeds From Government Assistance
ProceedsFromGovernmentAssistance
8000000 usd
CY2022Q2 sgry Grant Revenue
GrantRevenue
100000 usd
sgry Grant Revenue
GrantRevenue
1300000 usd
CY2021Q2 sgry Grant Revenue
GrantRevenue
4900000 usd
sgry Grant Revenue
GrantRevenue
20000000 usd
CY2022Q2 sgry Unrecognized Grant Funds Received
UnrecognizedGrantFundsReceived
4000000 usd
CY2021Q4 sgry Unrecognized Grant Funds Received
UnrecognizedGrantFundsReceived
4000000 usd
CY2022Q2 sgry Coronavirus Aid Relief And Economic Security Act Cares Act Government Grant Received Repayments
CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantReceivedRepayments
25000000 usd
sgry Coronavirus Aid Relief And Economic Security Act Cares Act Government Grant Received Repayments
CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantReceivedRepayments
43000000 usd
CY2022Q2 sgry Coronavirus Aid Relief And Economic Security Act Cares Act Government Grants Deferred Accelerated Payments
CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantsDeferredAcceleratedPayments
17000000 usd
CY2021Q4 sgry Coronavirus Aid Relief And Economic Security Act Cares Act Government Grants Deferred Accelerated Payments
CoronavirusAidReliefAndEconomicSecurityActCARESActGovernmentGrantsDeferredAcceleratedPayments
60000000 usd
CY2022Q2 sgry Variable Interest Entity Number Of Facilities
VariableInterestEntityNumberOfFacilities
6 facility
CY2022Q2 sgry Variable Interest Entity Number Of Facilities
VariableInterestEntityNumberOfFacilities
5 physician_practice
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
65800000 usd
CY2022Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
504300000 usd
CY2021Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
364600000 usd
CY2022Q2 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
15100000 usd
CY2021Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
16500000 usd
CY2022Q2 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
3087700000 usd
CY2021Q4 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
2938800000 usd
CY2022Q2 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
68300000 usd
CY2021Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
60400000 usd
CY2022Q2 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
3019400000 usd
CY2021Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
2878400000 usd
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
277800000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
324100000 usd
CY2022Q2 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
460200000 usd
CY2021Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
329600000 usd
CY2022Q2 sgry Lease Right Of Use Asset
LeaseRightOfUseAsset
738000000.0 usd
CY2021Q4 sgry Lease Right Of Use Asset
LeaseRightOfUseAsset
653700000 usd
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
35700000 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
40100000 usd
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
271800000 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
315600000 usd
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
307500000 usd
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
355700000 usd
CY2022Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
22700000 usd
CY2021Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
19000000.0 usd
CY2022Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
481600000 usd
CY2021Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
345600000 usd
CY2022Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
504300000 usd
CY2021Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
364600000 usd
CY2022Q2 sgry Lease Liability
LeaseLiability
811800000 usd
CY2021Q4 sgry Lease Liability
LeaseLiability
720300000 usd
sgry Increase Decrease In Finance Lease Liability
IncreaseDecreaseInFinanceLeaseLiability
146500000 usd
sgry Increase Decrease In Finance Lease Right Of Use Assets
IncreaseDecreaseInFinanceLeaseRightOfUseAssets
145000000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-60800000 usd
sgry Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
-59300000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
32700000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
37500000 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
18900000 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
13800000 usd
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
19700000 usd
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
12600000 usd
sgry Finance Lease Cost
FinanceLeaseCost
38600000 usd
sgry Finance Lease Cost
FinanceLeaseCost
26400000 usd
sgry Variable And Short Term Lease Cost
VariableAndShortTermLeaseCost
8500000 usd
sgry Variable And Short Term Lease Cost
VariableAndShortTermLeaseCost
9800000 usd
us-gaap Lease Cost
LeaseCost
79800000 usd
us-gaap Lease Cost
LeaseCost
73700000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
31700000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
36700000 usd
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
19600000 usd
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
11900000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
12100000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
10600000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
31100000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
31400000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
91900000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
6600000 usd
us-gaap Cash Flow Hedge Gain Loss To Be Reclassified Within Twelve Months
CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths
7200000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-18400000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-26900000 usd
CY2022Q2 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
1525900000 usd
CY2021Q4 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
1533600000 usd
CY2022Q2 us-gaap Derivative Asset Notional Amount
DerivativeAssetNotionalAmount
78900000 usd
CY2022Q2 us-gaap Derivative Liability Notional Amount
DerivativeLiabilityNotionalAmount
41700000 usd
CY2021Q4 us-gaap Derivative Asset Notional Amount
DerivativeAssetNotionalAmount
23600000 usd
CY2021Q4 us-gaap Derivative Liability Notional Amount
DerivativeLiabilityNotionalAmount
58200000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Reclassification For Discontinuance Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax
5300000 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Reclassification For Discontinuance Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax
3200000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Reclassification For Discontinuance Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax
10600000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Reclassification For Discontinuance Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax
3200000 usd
us-gaap Net Income Loss
NetIncomeLoss
-6200000 usd
us-gaap Net Income Loss
NetIncomeLoss
-47900000 usd
CY2022Q2 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0 usd
CY2021Q2 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0 usd
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0 usd
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
10300000 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-18400000 usd
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-26900000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6200000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-58200000 usd
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
88900000 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
69267000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
88450000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
62060000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
88900000 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
69267000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
88450000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62060000 shares
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.21
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.39
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.94
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.21
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.39
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.94
CY2022Q2 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0 usd
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0 usd
CY2021Q2 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0 usd
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
35700000 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
40100000 usd
CY2022Q2 us-gaap Interest Payable Current
InterestPayableCurrent
28800000 usd
CY2021Q4 us-gaap Interest Payable Current
InterestPayableCurrent
29200000 usd
CY2022Q2 srt Payables To Customers
PayablesToCustomers
32500000 usd
CY2021Q4 srt Payables To Customers
PayablesToCustomers
26000000.0 usd
CY2022Q2 sgry Cost Report Liabilities Current
CostReportLiabilitiesCurrent
22100000 usd
CY2021Q4 sgry Cost Report Liabilities Current
CostReportLiabilitiesCurrent
26400000 usd
CY2022Q2 sgry Tax Receivable Agreement Liability Current
TaxReceivableAgreementLiabilityCurrent
20200000 usd
CY2021Q4 sgry Tax Receivable Agreement Liability Current
TaxReceivableAgreementLiabilityCurrent
19700000 usd
CY2022Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
82500000 usd
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
68600000 usd
CY2022Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
221800000 usd
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
210000000.0 usd
CY2022Q2 us-gaap Self Insurance Reserve
SelfInsuranceReserve
18200000 usd
CY2021Q4 us-gaap Self Insurance Reserve
SelfInsuranceReserve
19800000 usd
CY2022Q2 us-gaap Estimated Insurance Recoveries
EstimatedInsuranceRecoveries
8700000 usd
CY2021Q4 us-gaap Estimated Insurance Recoveries
EstimatedInsuranceRecoveries
8700000 usd
CY2022Q1 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
32800000 usd
sgry Collaborative Tax Agreement Projected Tax Savings Term
CollaborativeTaxAgreementProjectedTaxSavingsTerm
P5Y
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.24
CY2022Q2 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
22000000 usd
CY2021Q4 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
22000000 usd
CY2022Q2 sgry Deferred Income Tax Liabilities Net Of Discount
DeferredIncomeTaxLiabilitiesNetOfDiscount
20700000 usd
CY2021Q4 sgry Deferred Income Tax Liabilities Net Of Discount
DeferredIncomeTaxLiabilitiesNetOfDiscount
19700000 usd
CY2022Q2 sgry Deferred Income Tax Liabilities Net Of Discount Current
DeferredIncomeTaxLiabilitiesNetOfDiscountCurrent
20200000 usd
CY2021Q4 sgry Deferred Income Tax Liabilities Net Of Discount Current
DeferredIncomeTaxLiabilitiesNetOfDiscountCurrent
19700000 usd
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
CY2022Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
615400000 usd
CY2021Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
543300000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1211600000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1055700000 usd
CY2022Q2 sgry Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
86100000 usd
CY2021Q2 sgry Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
75900000 usd
sgry Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
163200000 usd
sgry Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
148800000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
19600000 usd
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
6100000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
63700000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
17100000 usd
CY2022Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
33700000 usd
CY2021Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
35700000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
64300000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
67500000 usd
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
28000000.0 usd
CY2021Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
25200000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
55400000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
50900000 usd
CY2022Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-56900000 usd
CY2021Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-53400000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-113200000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-106700000 usd
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
4300000 usd
CY2021Q2 us-gaap Share Based Compensation
ShareBasedCompensation
4100000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
8000000.0 usd
us-gaap Share Based Compensation
ShareBasedCompensation
9300000 usd
CY2022Q2 sgry Business Combination Integration Related Costs And Merger Costs
BusinessCombinationIntegrationRelatedCostsAndMergerCosts
8200000 usd
CY2021Q2 sgry Business Combination Integration Related Costs And Merger Costs
BusinessCombinationIntegrationRelatedCostsAndMergerCosts
11400000 usd
sgry Business Combination Integration Related Costs And Merger Costs
BusinessCombinationIntegrationRelatedCostsAndMergerCosts
15300000 usd
sgry Business Combination Integration Related Costs And Merger Costs
BusinessCombinationIntegrationRelatedCostsAndMergerCosts
20800000 usd
CY2022Q2 sgry Gain Loss On Disposition Of Assets And Deconsolidation
GainLossOnDispositionOfAssetsAndDeconsolidation
-1100000 usd
CY2021Q2 sgry Gain Loss On Disposition Of Assets And Deconsolidation
GainLossOnDispositionOfAssetsAndDeconsolidation
-1000000.0 usd
sgry Gain Loss On Disposition Of Assets And Deconsolidation
GainLossOnDispositionOfAssetsAndDeconsolidation
-1000000.0 usd
sgry Gain Loss On Disposition Of Assets And Deconsolidation
GainLossOnDispositionOfAssetsAndDeconsolidation
-100000 usd
CY2022Q2 sgry Gain Loss Relatedto Litigation Settlement And Other Litigation Costs
GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts
-1700000 usd
CY2021Q2 sgry Gain Loss Relatedto Litigation Settlement And Other Litigation Costs
GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts
-800000 usd
sgry Gain Loss Relatedto Litigation Settlement And Other Litigation Costs
GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts
29100000 usd
sgry Gain Loss Relatedto Litigation Settlement And Other Litigation Costs
GainLossRelatedtoLitigationSettlementAndOtherLitigationCosts
-1800000 usd
CY2022Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2021Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-9600000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-9600000 usd
CY2022Q2 sgry Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
86100000 usd
CY2021Q2 sgry Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
75900000 usd
sgry Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
163200000 usd
sgry Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
148800000 usd
CY2022Q2 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
8200000 usd
CY2021Q2 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
9200000 usd
CY2021Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
2200000 usd
us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
15300000 usd
us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
14500000 usd
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
6300000 usd
CY2022Q2 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
1700000 usd
CY2021Q2 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
800000 usd
us-gaap Litigation Settlement Expense
LitigationSettlementExpense
3700000 usd
us-gaap Litigation Settlement Expense
LitigationSettlementExpense
1800000 usd
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
32800000 usd
CY2022Q2 us-gaap Assets
Assets
6291600000 usd
CY2021Q4 us-gaap Assets
Assets
6117600000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
40600000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
28000000.0 usd

Files In Submission

Name View Source Status
0001638833-22-000122-index-headers.html Edgar Link pending
0001638833-22-000122-index.html Edgar Link pending
0001638833-22-000122.txt Edgar Link pending
0001638833-22-000122-xbrl.zip Edgar Link pending
a2022q2exhibit311.htm Edgar Link pending
a2022q2exhibit312.htm Edgar Link pending
a2022q2exhibit321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sgry-20220630.htm Edgar Link pending
sgry-20220630.xsd Edgar Link pending
sgry-20220630_cal.xml Edgar Link unprocessable
sgry-20220630_def.xml Edgar Link unprocessable
sgry-20220630_htm.xml Edgar Link completed
sgry-20220630_lab.xml Edgar Link unprocessable
sgry-20220630_pre.xml Edgar Link unprocessable
Show.js Edgar Link pending